He has submitted his resignation and will effective at the end of March. I can guarantee this is not a fun job right now with the recalls and all the issues the DePuy division has faced. He’s an executive in charge of running a failing implant
division, and personally he did not create the units, nor did he implant any of them but it’s his bowl of wax, well at least until the end of the month. Sometimes when in positions as such with recalls and failures, you might wonder does anyone really want that job? I wouldn’t as you are not going to be able to please very many people and opinions at all. In the meantime if one company can’t make an implant that works, maybe go buy another, at least that is what it looks like with recent news.
Johnson and Johnson Set to Make Another Offer To Smith & Nephew-Going After One More Orthopedic Acquisition in the UK Meanwhile Consumer Confidence Is Limited
This one was already announced as a buy out.
Johnson and Johnson Company, DePuy Orthopedics Acquires Finsbury Orthopaedics from the UK
The reason for leaving is cited as pursuing interests outside the company and again if I were in that pressure cooker it would sound like good reasoning to me. BD
Johnson & Johnson said Friday that the worldwide president of its DePuy Orthopaedics division, a maker of artificial hips and knees that has struggled with product recalls and lawsuits over faulty implants, is leaving the company. The executive, David Floyd, submitted his resignation last week and will leave at the end of March, a spokeswoman said.
Johnson & Johnson Implant Unit Executive Resigns - NYTimes.com









![EZClaim[4] EZClaim[4]](http://lh4.ggpht.com/_v3zjJigoAPE/TG1-9etl5ZI/AAAAAAAAgqg/CRMlet5Pi5k/EZClaim44.png?imgmax=800)












Math–This Could be a Subject for Michael Moore to Explore and Document In a Movie


Duping” Society Combined With A World of Rogue Algorithms & Flawed Data Continues In Markets As Seen With Knight Capital This Week-Attack of the Killer Algorithms Chapter 36
Study Fraud With EHR Technologies, Namely Medical Records/Billing Software Used by Hospitals– HHS And SEC Continue Getting Their Non-Algorithmic Fannies Kicked–Attack of the Killer Algorithms Chapter 46
SilverScript Senior Drug Program Sanctioned by Medicare Until the Payment And Billing Algorithms are Cleaned Up-Killer Algorithms Chapter 53
